BMED vs OZEM: Holdings Overlap & Returns

Over the year to Nov 13, 2026, BMED returned +25.4% to OZEM's +0.7%; 9% of their weight is in the same names.

Return gap
+24.7 pts1 year to Nov 13, 2026: BMED ahead, total return
Fee gap
0.04 ptsA year: BMED 0.55%, OZEM 0.59%, per filings dated Nov 21, 2025 and Apr 30, 2026
Overlap
9%Share of the two books held in common, holdings dated Nov 12, 2026 and Nov 13, 2026
Net flow
$0k / −$1mBMED / OZEM, Oct 13, 2026 to Nov 12, 2026, daily basis
The answerOne drawing that carries it.

Compare two other funds

The evidenceWhy, in charts and cards.
BMED and OZEM · 1 year

Growth of 100

BMED +25.4%OZEM +0.7%
Growth of 100 in BMED and OZEM over 1 year, Nov 13, 2025 to Nov 13, 2026, with distributions reinvested. BMED ends at 125.4 (+25.4%), OZEM at 100.7 (+0.7%).

BMED +25.4%, OZEM +0.7%: BMED +24.7 pts ahead, 1 year, Nov 13, 2025 to Nov 13, 2026.

Share

Use this comparison

Alert

BMED and OZEM flows, by email on Sundays.

One-click unsubscribe. See Privacy.

Hypothetical · drag the order size

Cost to trade

Hypothetical. A $10,000 order in BMED costs about $11.50 one way and $23.00 in and out, at a median spread of 0.23%. The 0.23% spread is BMED’s 30-day median, from iShares (fund page).

Hypothetical · drag to set

Fees over time

Hypothetical. $10,000 in OZEM for 10 years at 0.59% a year costs about $972 in fees and lost growth; BMED at 0.55% would cost $908. Assumes 6% a year before fees, a sample rate, not a forecast.

How each fund moved

BMED · 1 year to Nov 13, 202642% of its weight is outside the S&P 500
42% of its weight is outside the S&P 50058% of BMED's weight is in S&P 500 companies and 42% is outside the index. Holdings as of Nov 12, 2026.58%42%of its weight in S&P 500 companiesof its weight outside the S&P 500active share 96% · top ten 44% of the fund · 55 holdings as published by its issuer for Nov 12, 2026 · Nasdaq-100: 14% in42% of its weight is outside the S&P 50058% of BMED's weight is in S&P 500 companies and 42% is outside the index. Holdings as of Nov 12, 2026.58%42%in the S&P 500outsideactive share 96% · Nasdaq-100: 14% in

58% of BMED's weight is in S&P 500 companies and 42% is outside the index. Holdings as of Nov 12, 2026.

OZEM · 1 year to Nov 13, 202670% of its weight is outside the S&P 500
70% of its weight is outside the S&P 50030% of OZEM's weight is in S&P 500 companies and 70% is outside the index. Holdings as of Nov 13, 2026.30%70%in the S&P 500of its weight outside the S&P 500active share 98% · top ten 72% of the fund · 21 holdings as published by its issuer for Nov 13, 2026 · Nasdaq-100: 4% in70% of its weight is outside the S&P 50030% of OZEM's weight is in S&P 500 companies and 70% is outside the index. Holdings as of Nov 13, 2026.30%70%inoutside the S&P 500active share 98% · Nasdaq-100: 4% in

30% of OZEM's weight is in S&P 500 companies and 70% is outside the index. Holdings as of Nov 13, 2026.

Key numbers

BMED in the S&P 500
58.2%
OZEM in the S&P 500
30.4%
BMED total return, 1 year
+25.4%
OZEM total return, 1 year
+0.7%

BMED costs 0.04 points a year less; their one-year returns differ by 24.7 points; OZEM is 3.8 times larger.

Pair scorecard

Open the table

Points (pts) are percentage points.

Total return, 1 year+25.4%+0.7%
Below its all-time high15.1%, high on Jan 26, 2026
What it tracksHealthcare innovation and GLP-1Healthcare innovation and GLP-1
Expense ratio0.55%0.59%
Net assets$15m$57m
Holdings in common9%

The numbers behind it

Net assets on Nov 13, 2026: $15m for iShares Health Innovation Active ETF and $57m for Roundhill GLP-1 & Weight Loss ETF.

Holdings in common uses holdings dated Nov 12, 2026 and Nov 13, 2026.

What they share

By the books each fund has filed, BMED and OZEM hold 9% of their money in the same securities at the same weight. Holdings dated Nov 12, 2026 and Nov 13, 2026.

0half (50%)100%

half

9% in common

Held in common

Show all 5 holdings
ROCHE PS PAR AG2.85%2.70%
AMGEN INC2.57%2.99%
PFIZER1.46%5.69%
GILEAD SCIENCES5.80%1.39%
MBX BIOSCIENCES0.41%1.75%

Only in BMED

Show all 8 holdings
MODERNA5.52%
DANAHER5.15%
ABBVIE4.91%
THERMO FISHER SCIENTIFIC4.33%
EDWARDS LIFESCIENCES4.25%
BIOGEN3.70%
METTLER-TOLEDO INTERNATIONAL INC3.61%
IQVIA HOLDINGS INC3.58%

Only in OZEM

Show all 8 holdings
Eli Lilly & Co20.30%
Novo Nordisk A/S10.86%
Hanmi Pharm Co Ltd6.97%
Chugai Pharmaceutical Co Ltd6.82%
Kailera Therapeutics Inc4.89%
CSPC Pharmaceutical Group Ltd4.56%
Jiangsu Hengrui Pharmaceuticals Co Ltd4.16%
Viking Therapeutics Inc3.94%

Side by side

Open the table
FundiShares Health Innovation Active ETF · Holds 55 stocks in healthcare innovation and GLP-1, 58% of its weight in S&P 500 companiesRoundhill GLP-1 & Weight Loss ETF · Holds 21 stocks in healthcare innovation and GLP-1, 30% of its weight in S&P 500 companies
IssueriSharesRoundhill
ThemeHealthcare innovation and GLP-1Healthcare innovation and GLP-1
In the S&P 50058.2%30.4%
Active share vs the S&P 50095.6%97.8%
In the Nasdaq-10013.8%4.4%
Holdings5521
Top ten, share of the fund44.1%72.0%
Expense ratio0.55%0.59%
Fee for the differing part0.58%0.60%
Total return, 1 year+25.4%+0.7%
vs its benchmarknot measurednot measured
Below its high−2.7%−15.1%
Net assets$15m$57m

As of Nov 13, 2026. Source: ETFIQ.

Window by window

Open the table
3 months+12.9%−4.9%
6 months+33.6%+1.8%
1 year+25.4%+0.7%
3 years+68.1%–
Since launch (Not the same days: BMED Oct 2020 · OZEM May 2024)+42.8%+25.6%

– means no data for this window.

About BMED

By weight, 58% of BMED's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 96%. The top ten holdings are 44% of the fund across 55 positions, as published by its issuer for Nov 12, 2026.

More

Over the year to Nov 13, 2026 the fund returned +25.4% with distributions reinvested.

About OZEM

By weight, 30% of OZEM's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 98%. The top ten holdings are 72% of the fund across 21 positions, as published by its issuer for Nov 13, 2026.

More

Over the year to Nov 13, 2026 the fund returned +0.7% with distributions reinvested. It sits 15.1% below its all-time high of Jan 26, 2026.

9% of the two portfolios are the same securities at the same weight.

Questions people ask

Do BMED and OZEM hold the same stocks?

By their latest filings, 9% of their books are the same securities at the same weight. Overlap is the sum of the smaller weight of every security they share.

Which is more different from the S&P 500, BMED or OZEM?

BMED has 58% of its weight in S&P 500 names and OZEM has 30%, so OZEM differs more from the index.

Which is cheaper, BMED or OZEM?

BMED charges 0.55% a year and OZEM charges 0.59%, so BMED is cheaper. Fees come from each fund's prospectus.

Other comparisons

Sources

More

Links are sources, not endorsements. A comparison is not a recommendation.

Copy and cite

Cite this pageCitation, APA and Markdown

ETFIQ, BMED against OZEM, data as of Nov 13, 2026. https://etfiq.com/compare/themes/bmed-vs-ozem

Open data

Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms.